ephos-online.org

EPHOS
Slider1

Welcome Message

Prof. Alaa Elhaddad

Dear Colleagues

 

On behalf of the Egyptian Pediatric Hematology Oncology Society (EPHOS) and Children’s Cancer Hospital of Egypt (CCHE-57357) organizing Committee we would like to invite you to attend the 2nd EPHOS Annual International Conference about “Shaping the Future of Pediatric Hematology Oncology” on October 5-7, 2023 at Triumph Plaza Hotel Cairo,  Egypt.

This scientific event will include a selection of educational sessions related to the current practice and challenges of pediatric hematologic and solid malignancies, infectious diseases, hematopoietic stem cell transplantation, Immunodeficiency and cell therapy. 

The program will be led by experts and distinguished speakers from different leading institutions worldwide.

We are thrilled to include two distinctive sessions one about “CAR T Cell Therapy” and how this innovative immunotherapy can transform the treatment of the children with leukemia, lymphoma and other malignancies. The other one is about Primary Immune Dysregulation, this session is sponsored by Jeffrey Modell Foundation, a global leader in promoting research, education and awareness of primary immunodeficiency

The event represents an opportunity to explore breakthroughs in Pediatric oncology topics and make valuable connections with national and international figures who are experts in the field.

We believe that your contribution to the conference will be a valuable asset.

Please, do not hesitate to contact us if you have any question at the following contact info: Prof Dr. Mahmoud Hammad; Secretary General of EPHOS Conference (Mahmoud.hammad@nci.cu.edu.eg).

Until then, Thank you and beast wishes 

Prof. Dr.  Alaa Elhaddad
Conference President

Prof Dr.  Sherif Abouelnaga
CEO Children’s Cancer Hospital – Egypt 5735725

Hurry Up to Register

2023 EPHOS Board

Honorary President

Prof. Sherif Aboulnaga-2

Prof. Dr. Sherif Abouelnaga

Prof. of Pediatric Hematology/Oncology, NCI, Cairo University, Egypt CEO and General Manager Children's Cancer Hospital - Egypt 57357

Conference Chairman

Prof. Alaa Elhaddad

Prof. Dr. Alaa El Haddad​

Prof. of Pediatric Hematology/Oncology, NCI, Cairo University, Egypt Head of Pediatric Oncology Department, CCHE- 57357

Conference Co-Chairmen

Prof. Iman Sidhom

Prof. Dr. Iman Sidhom

Head of Pediatric Oncology Department, NCI, Cairo University
Senior Consultant of Pediatric Hematology/Oncology, CCHE-57357
Prof. Emad Ebeid

Prof. Dr. Emad Ebied

Prof. of Pediatric Hematology/Oncology, NCI, Cairo University, Egypt
Prof. Mohamed Fawzy

Prof. Dr. Mohamed Fawzy

Prof of Pediatric Hematology/Oncology, NCI/Cairo University

Senior Consultant of Pediatric Hematology/Oncology, CCHE-57357

Prof. Hanafy Hafez

Prof. Dr. Hanafy Hafez

Prof of Pediatric Hematology/Oncology, NCI/Cairo University
Senior Consultant of Pediatric Hematology/Oncology, CCHE-573579
Prof. Dr. Shady Fadel

Prof. Dr. Shady Fadel

Prof. of Pediatric oncology, Alexandria University
Director Borg El Arab Pediatric Oncology Center

Conference General Secretary

Dr. Mahmoud Hammad

Prof. Dr. Mahmoud Hammad

Ass. Prof. of Pediatric Hematology/Oncology, NCI, Cairo University

Consultant Of Pediatric Hematology/Oncology, CCHE- 57357

Scientific & Organizing Committee Director

Prof. Moatasem Elayadi

Prof. Dr. Moatasem Elayadi

Ass Prof of Pediatric Hematology/Oncology, NCI/Cairo University

Consultant of Pediatric Hematology/Oncology, CCHE-57357

Scientific & Organizing Committee Members

Prof.-Hisham-Moneib

Dr. Hisham Moneib

Consultant of Pediatric Hematology/Oncology, CCHE-57357
Dr. Ahmed Obeid

Dr. Ahmed Obeid

Ass. Consultant of Pediatric Hematology/Oncology, CCHE-57357

Dr. Rana Ahmed

Children's cancer Hospital Egypt 57357

Dr. Nessma Mahmoud

Children's cancer Hospital Egypt 57357

Main Topics

  • Car T Cell & Cellular Therapy .
  • Diagnosis and Bone Marrow Marrow Transplant of Primary Immune Regulatory Disorders .
  • Infectious Diseases .
  • Cancer Research .
  • Lymphoma .
  • Leukemia .
  • Bone Marrow Transplant .
  • Solid Tumors .
  • Retinoblastoma .